Bergenbio ASA Cash Flow-to-Debt Ratio
Bergenbio ASA cash flow-to-debt ratio. Bergenbio ASA (BGBIO) has a Cash Flow-to-Debt Ratio of -4.63x as of December 2024, meaning its operating cash flow of Nkr-153.24 Million could theoretically repay -5% of its total liabilities (Nkr33.09 Million) in one year. See Bergenbio ASA (BGBIO) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bergenbio ASA (2015–2024)
Cash flow-to-debt ratio of Bergenbio ASA from 2015 to 2024. Historical debt coverage capacity for Bergenbio ASA across 10 annual periods. Also explore net asset growth rate of Bergenbio ASA to track the company's year-over-year net asset growth rate.
Bergenbio ASA Cash Flow-to-Debt Ratio by Year (2015–2024)
Bergenbio ASA cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Bergenbio ASA. For the full cash flow conversion analysis, see Bergenbio ASA cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.63x | Nkr-153.24 Million | Nkr33.09 Million | ▲ +22.6% |
| 2023 | -5.99x | Nkr-280.50 Million | Nkr46.86 Million | ▼ -62.4% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr65.81 Million | ▼ -33.7% |
| 2020 | -3.45x | Nkr-234.29 Million | Nkr67.97 Million | ▲ +5.2% |
| 2019 | -3.64x | Nkr-184.15 Million | Nkr50.62 Million | ▲ +19.1% |
| 2018 | -4.49x | Nkr-186.71 Million | Nkr41.55 Million | ▲ +9.1% |
| 2017 | -4.95x | Nkr-168.11 Million | Nkr33.99 Million | ▲ +15.4% |
| 2016 | -5.85x | Nkr-124.31 Million | Nkr21.27 Million | ▼ -64.0% |
| 2015 | -3.56x | Nkr-62.90 Million | Nkr17.64 Million | — |